Fed’s Powell opens door to potential rate cuts at Jackson Hole
CHICAGO—Charles P. Carey, a director at CME Group Inc. (NASDAQ:CME), recently executed sales of the company’s Class A common stock, according to a filing with the Securities and Exchange Commission. On June 10, Carey sold a total of 500 shares, fetching prices between $265.35 and $265.36 per share. The transactions amounted to a total of $132,676. The sales occurred as CME Group, currently valued at approximately $96 billion, trades near its InvestingPro Fair Value with a "GOOD" financial health rating.
Following these sales, Carey holds 4,900 shares directly through a trust. The sales were conducted in two separate transactions of 150 and 350 shares, respectively. This activity follows routine trading practices by insiders, providing a glimpse into the stock management strategies of company executives. InvestingPro data shows CME has maintained dividend payments for 23 consecutive years, with a current dividend yield of 4.06% and recent dividend growth of 9.64%. Get deeper insights into CME’s insider trading patterns and comprehensive analysis with an InvestingPro subscription.
In other recent news, CME Group reported a record average daily trading volume for May 2025, with 28.9 million contracts traded, marking an 11% increase from the previous year. This robust trading activity spanned various asset classes, including interest rates, metals, and cryptocurrencies. UBS analysts reaffirmed a Buy rating on CME Group stock, although they slightly adjusted their earnings per share estimate for the second quarter of 2025 due to moderated futures volume. Despite this, UBS remains optimistic about the company’s future, citing strong cash market activity and ongoing geopolitical uncertainties. In contrast, Erste Group downgraded CME Group stock from Buy to Hold, citing an expected slowdown in turnover and net profit growth. Barclays (LON:BARC) maintained an Equalweight rating, noting a 4% month-over-month revenue increase from BrokerTec and EBS in April. Additionally, CME Group announced the launch of four new cryptocurrency reference rates in collaboration with CF Benchmarks, expanding their offerings to include Arbitrum, Ondo, NEAR, and Sui. This move aims to provide transparent pricing data for these digital assets as the cryptocurrency market matures.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.